Department of Neuroscience, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
J Neurosurg Anesthesiol. 2023 Apr 1;35(2):208-214. doi: 10.1097/ANA.0000000000000816. Epub 2021 Oct 18.
It was recently reported that lower intracranial pressure variability (ICPV) is associated with delayed ischemic neurological deficits and unfavorable outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). In this study, we aimed to determine whether lower ICPV also correlated with worse cerebral energy metabolism after aSAH.
A total of 75 aSAH patients treated in the neurointensive care unit at Uppsala University Hospital, Sweden between 2008 and 2018 and with both intracranial pressure and cerebral microdialysis (MD) monitoring during the first 10 days after ictus were included in this retrospective study. ICPV was calculated with a bandpass filter limited to intracranial pressure slow waves with a wavelength of 55 to 15 seconds. Cerebral energy metabolites were measured hourly with MD. The monitoring period was divided into 3 phases; early (days 1 to 3), early vasospasm (days 4 to 6.5), and late vasospasm (days 6.5 to 10).
Lower ICPV was associated with lower MD-glucose in the late vasospasm phase, lower MD-pyruvate in the early vasospasm phases, and higher MD-lactate-pyruvate ratio (LPR) in the early and late vasospasm phases. Lower ICPV was associated with poor cerebral substrate supply (LPR >25 and pyruvate <120 µM) rather than mitochondrial failure (LPR >25 and pyruvate >120 µM). There was no association between ICPV and delayed ischemic neurological deficit, but lower ICPV in both vasospasm phases correlated with unfavorable outcomes.
Lower ICPV was associated with an increased risk for disturbed cerebral energy metabolism and worse clinical outcomes in aSAH patients, possibly explained by a vasospasm-related decrease in cerebral blood volume dynamics and cerebral ischemia.
最近有报道称,颅内压变异性(ICPV)降低与动脉瘤性蛛网膜下腔出血(aSAH)患者的迟发性缺血性神经功能缺损和不良结局相关。在这项研究中,我们旨在确定 ICPV 降低是否也与 aSAH 后更差的脑能量代谢有关。
本回顾性研究纳入了 2008 年至 2018 年期间在瑞典乌普萨拉大学医院神经重症监护病房接受治疗的 75 例 aSAH 患者,这些患者在发病后 10 天内接受了颅内压和脑微透析(MD)监测。ICPV 通过带通滤波器计算,限制在颅内压慢波的波长为 55 至 15 秒。脑能量代谢物每小时用 MD 测量一次。监测期分为 3 个阶段:早期(第 1 至 3 天)、早期血管痉挛(第 4 至 6.5 天)和晚期血管痉挛(第 6.5 至 10 天)。
ICPV 降低与晚期血管痉挛期 MD-葡萄糖降低、早期血管痉挛期 MD-丙酮酸降低以及早期和晚期血管痉挛期 MD-乳酸-丙酮酸比值(LPR)升高有关。较低的 ICPV 与脑底物供应不良(LPR >25 和丙酮酸 <120μM)相关,而不是线粒体功能衰竭(LPR >25 和丙酮酸 >120μM)。ICPV 与迟发性缺血性神经功能缺损之间无相关性,但两个血管痉挛期的 ICPV 降低均与不良结局相关。
较低的 ICPV 与 aSAH 患者的脑能量代谢紊乱和不良临床结局的风险增加相关,这可能是由于血管痉挛导致脑血容量动力学和脑缺血相关的下降引起的。